US Patent 7326705 Heterocyclic sodium/proton exchange inhibitors and method
Patent 7326705 was granted and assigned to Bristol-Myers Squibb on February, 2008 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7326705 Heterocyclic sodium/proton exchange inhibitors and method
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
